French drug-making group Sanofi has reported that net profit slipped in the third quarter but that its main treatments were doing well and research for new drugs including a dengue fever vaccine looked promising. But the price of shares in the group plunged by 7.01 percent in initial trading in response to the news that net profit had fallen by 2.4 percent from the equivalent figure last year to 1.19 billion euros ( (Dollar) 1.51 billion). The company blamed ...
Read More
You have just read an article categorized health
titled Sanofi Attains Targets Despite Profit Slip, Shares Plunge.
Written by:
editor -
Wednesday, October 29, 2014
There are currently no comments for "Sanofi Attains Targets Despite Profit Slip, Shares Plunge"
Post a Comment